Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
Journal of Gastroenterology and Hepatology|February 16, 2026
A Novel Fibroblast Activation Protein-Based Algorithm to Assess Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZiqi V Wang, Badwi B Boumelhem, Torsten Pennell, et al.Hepatology Communications|April 14, 2025
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysisJiajing Li, Jiahua Zhou, Pengfei Li, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohortLiang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, et al.Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.Gastroenterology|May 8, 2018
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort StudyEduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.The Lancet. Gastroenterology & Hepatology|December 20, 2019
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology CommissionShiv K Sarin, Manoj Kumar, Mohammed Eslam, et al.Hepatology International|September 24, 2022
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLDLiang-Jie Tang, Gang Li, Mohammed Eslam, et al.The Journal of Clinical Endocrinology and Metabolism|May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 18, 2021
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 LocusAli Bayoumi, Asmaa Elsayed, Shuanglin Han, et al.Metabolism: Clinical and Experimental|December 27, 2021
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLDLiang-Jie Tang, Hong-Lei Ma, Mohammed Eslam, et al.Pageof 18